| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
ORIGINAL RESEARCH COMMUNICATION |
1 From the School of Population Health, University of Queensland, Brisbane, Australia (TC and AD); the Epidemiology Services Unit, Health Information Branch, Queensland Health, Brisbane, Australia (TC, TII, and CM); the Viertel Center for Research in Cancer Control, Queensland Cancer Fund, Brisbane, Australia (PDB); Oxfam, Oxford (SD) Tropical Public Health Unit, Queensland Health, Cairns, Australia (DL); and the International Diabetes Institute, Melbourne, Australia (JS)
Background: Epidemiologic evidence suggests that serum carotenoids are potent antioxidants and may play a protective role in the development of chronic diseases including cancers, cardiovascular disease, and inflammatory diseases. The role of these antioxidants in the pathogenesis of diabetes mellitus remains unclear.
Objective: This study examined data from a cross-sectional survey to investigate the association between serum carotenoids and type 2 diabetes.
Design: Study participants were adults aged 
25 y (n = 1597) from 6 randomly selected cities and towns in Queensland, Australia. Study examinations conducted between October and December 2000 included fasting plasma glucose, an oral-glucose-tolerance test, and measurement of the serum concentrations of 5 carotenoid compounds.
Results: Mean 2-h postload plasma glucose and fasting insulin concentrations decreased significantly with increasing quintiles of the 5 serum carotenoids—
-carotene, ß-carotene, ß-cryptoxanthin, lutein/zeaxanthin, and lycopene. Geometric mean concentrations for all serum carotenoids decreased (all decreases were significant except that of lycopene) with declining glucose tolerance status. ß-Carotene had the greatest decrease, to geometric means of 0.59, 0.50, and 0.42 µmol/L in persons with normal glucose tolerance, impaired glucose metabolism, and type 2 diabetes, respectively (P < 0.01 for linear trend), after control for potential confounders.
Conclusions: Serum carotenoids are inversely associated with type 2 diabetes and impaired glucose metabolism. Randomized trials of diets high in carotenoid-rich vegetables and fruit are needed to confirm these results and those from other observational studies. Such evidence would have very important implications for the prevention of diabetes.
Key Words: Type 2 diabetes • diabetes mellitus • impaired glucose tolerance • serum carotenoids • -carotene • ß-carotene • ß-cryptoxanthin • lutein/zeaxanthin • lycopene • antioxidant vitamins • diet • cross-sectional surveys • health surveys • nutrition
This article has been cited by other articles:
|
|
 |
|
  L. Wang, J M. Gaziano, E. P Norkus, J. E Buring, and H. D Sesso Associations of plasma carotenoids with risk factors and biomarkers related to cardiovascular disease in middle-aged and older women Am. J. Clinical Nutrition, September 1, 2008; 88(3): 747 - 754. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Kowluru, B. Menon, and D. L. Gierhart Beneficial Effect of Zeaxanthin on Retinal Metabolic Abnormalities in Diabetic Rats Invest. Ophthalmol. Vis. Sci., April 1, 2008; 49(4): 1645 - 1651. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Wang, S. Liu, A. D. Pradhan, J. E. Manson, J. E. Buring, J. M. Gaziano, and H. D. Sesso Plasma Lycopene, Other Carotenoids, and the Risk of Type 2 Diabetes in Women Am. J. Epidemiol., September 15, 2006; 164(6): 576 - 585. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Hozawa, D. R. Jacobs Jr., M. W. Steffes, M. D. Gross, L. M. Steffen, and D.-H. Lee Associations of Serum Carotenoid Concentrations with the Development of Diabetes and with Insulin Concentration: Interaction with Smoking: The Coronary Artery Risk Development in Young Adults (CARDIA) Study Am. J. Epidemiol., May 15, 2006; 163(10): 929 - 937. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
